Argenica Therapeutics Ltd
ASX:AGN

Watchlist Manager
Argenica Therapeutics Ltd Logo
Argenica Therapeutics Ltd
ASX:AGN
Watchlist
Price: 0.255 AUD -1.92% Market Closed
Market Cap: 32.8m AUD

Intrinsic Value

The intrinsic value of one AGN stock under the Base Case scenario is 0.043 AUD. Compared to the current market price of 0.255 AUD, Argenica Therapeutics Ltd is Overvalued by 83%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AGN Intrinsic Value
0.043 AUD
Overvaluation 83%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Argenica Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about AGN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AGN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Argenica Therapeutics Ltd.

Explain Valuation
Compare AGN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AGN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Argenica Therapeutics Ltd

Current Assets 11m
Cash & Short-Term Investments 10.6m
Receivables 421.5k
Other Current Assets 61.3k
Non-Current Assets 1k
Intangibles 1k
Current Liabilities 3.8m
Accounts Payable 3.1m
Accrued Liabilities 58.3k
Other Current Liabilities 615.9k
Efficiency

Free Cash Flow Analysis
Argenica Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Argenica Therapeutics Ltd

Revenue
512.8k AUD
Operating Expenses
-10.7m AUD
Operating Income
-10.2m AUD
Other Expenses
3m AUD
Net Income
-7.2m AUD
Fundamental Scores

AGN Profitability Score
Profitability Due Diligence

Argenica Therapeutics Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

41/100
Profitability
Score

Argenica Therapeutics Ltd's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

AGN Solvency Score
Solvency Due Diligence

Argenica Therapeutics Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
75/100
Solvency
Score

Argenica Therapeutics Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AGN Price Targets Summary
Argenica Therapeutics Ltd

There are no price targets for AGN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Argenica Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for AGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one AGN stock?

The intrinsic value of one AGN stock under the Base Case scenario is 0.043 AUD.

Is AGN stock undervalued or overvalued?

Compared to the current market price of 0.255 AUD, Argenica Therapeutics Ltd is Overvalued by 83%.

Back to Top